Anti-VEGF and anti-complement therapies work on distinct mechanisms in age-related macular degeneration, and both may be required to treat patients with advanced disease or complex cases.

The DRD Cure Accelerator, highlighted at the CCOI-Stanford Summit, is a global initiative advancing clinical research and ...

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

While the detachment itself rarely threatens vision, the physical separation process creates significant traction that occasionally tears the retina, making prompt evaluation essential to ...

A case report published in BMC Ophthalmology has highlighted an extremely rare complication of botulinum toxin A (BTA) ...

New eye drops slow vision loss in animals Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa Date: March 21, 2025 Source: NIH ...

Vision Loss or Shadows Partial blindness, i.e., reduced peripheral vision or inability to see in dim light, can be a sign of advanced retinopathy or retinal detachment.

Those can leak and scar the macula, causing a partial or total loss of central vision. Who’s at risk: Being over 75 triples your risk, Bajic says.

Contrary to popular belief, most people who are blind have some vision—only about 15% of blindness results in total vision loss. Blindness can occur at any point in life, but it's most common ...

Severe, progressive, irreversible vision decline or loss is inevitable. Almost all patients will have a bilateral retinal detachment before the age of 10 years.